Copyright © Inderes 2011 - present. All rights reserved.
  • Seneste
  • Markeder
    • Aktieoversigt
    • Finanskalender
    • Udbyttekalender
    • Research
    • Artikler
  • InderesTV
  • Forum
  • Om os
    • Fulgte selskaber
    • Team
Selskabsmeddelelse

Swedencare AB (publ) Communiqué from the Annual General Meeting 2024

Swedencare
Download udgivelse

At Swedencares Annual General Meeting, on April 25, 2024, the following decisions were made:

Adoption of the income statement and balance sheet

The Annual General Meeting decided on the adoption of the income statement and balance sheet as well as consolidated income statement and consolidated balance sheet for the financial year 2023.

Dispositions regarding the Company´s profit

The Annual General Meeting decided on a dividend of SEK 0.23 per share, corresponding to a total of 36,508,337 SEK. The recording date for the right to receive dividends is decided to be April 29th, 2024. Dividends are expected to be paid through Euroclear Sweden AB on May 3rd, 2024.

Discharge from liability towards the Company for the Board members and the CEO

The Annual General Meeting decided to grant discharge from liability towards the Company to the Board members and the CEO for the year 2023.

Determination of fees to the Board and Auditor

The Annual General Meeting decided on Board fees of a total of 1,950,000 SEK to be distributed with 700,000 SEK to the Chairman and 250,000 SEK each to other members elected by the Annual General Meeting, except Jean-Yves Parisot that represents Symrise Group. For committee work, to the members appointed by the board: 125,000 SEK to the chairman of the audit committee. No compensation is paid to the chairman of the remuneration committee and the other members of the committee.

Auditor fee according to approved bill.

Election of Board members, Chairman of the Board, and auditor

The Annual General Meeting decided on re-electing the board members Håkan Svanberg, Johan Bergdahl, Thomas Eklund, Sara Brandt, Ulrika Valassi, Jean-Yves Pariot and Heinz-Juergen Bertram. The Annual General Meeting decided to elect Håkan Svanberg as Chairman of the Board.

The Annual General Meeting decided to re-elect Deloitte AB with Maria Ekelund as principal auditor for the period until the end of the Annual General Meeting of 2025.

Principles for the appointment of a nomination committee

The Annual General Meeting decided to adopt principles for the appointment of a nomination committee meaning mainly that the three (3) largest shareholders of the company per September 30th have the right to appoint a member to the nomination committee.

Authorization for the Board of Directors to resolve on the issue of shares

The Annual General Meeting decided to authorize the Board of Directors to, on one or more occasions during the period until the next Annual General Meeting, decide to increase the company's share capital by a maximum of 17 636 878 shares through a new issue of shares. The Board shall be able to decide on the issue of shares with deviation from the shareholders' preferential rights and/or with a provision on non-cash, set-off or otherwise with conditions in accordance with Chapter 2, § 5, second paragraph 1-3 and 5 of the Companies Act.

Resolution on amendments to the Articles of Association

The annual general meeting decided, in accordance with the proposal from the board, to introduce an amendment in the company's articles of association allowing the board to decide that the general meeting shall be held digitally.

For more information, please contact:


Håkan Lagerberg, CEO Swedencare
Phone: +46 (0)73 517 01 70
Email: hakan.lagerberg@swedencare.se

Jenny Graflind, CFO Swedencare
Phone: +46 (0)73 944 85 54
Email: jenny.graflind@swedencare.se

FNCA is the Certified Adviser of the Company

Please visit the Company homepage www.swedencare.com

About Swedencare


Swedencare, a listed company on NASDAQ First North Growth Market, develops, produces and sells premium products in the global and fast-growing market for healthcare products for cats, dogs and horses. The company has an extensive product portfolio with strong brands such as NaturVet®, Innovet, Pet MD®, Rx Vitamins®, nutravet®, and ProDen PlaqueOff®, the original for good oral health. Swedencare’s headquarter is in Malmö, Sweden and the company's products are currently sold in approximately sixty-five countries to veterinarians, pet stores, and online through a distribution network, including subsidiaries in nine countries and an international network of retailers. Swedencare's sales have increased significantly over several years with maintained high profitability.

Attachments


Swedencare AB (publ) Communiqué from the Annual General Meeting 2024

Find os på de sociale medier
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Tag kontakt
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • Om os
  • Vores team
  • Karriere
  • Inderes som en investering
  • Tjenester for børsnoterede virksomheder
Vores platform
  • FAQ
  • Servicevilkår
  • Privatlivspolitik
  • Disclaimer
Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.